Biosynex to merge with Theradiag.

Financials

Edit Data

Transaction Value-

Consideration TypeCash

Capital Owned-

Capital Bid For100%

EV/Sales-

EV/EBITDA-

Share Price Premium-

One Off Charge-

target

THERADIAG

bidder

BIOSYNEX

Sources

Edit

Tags

Edit

Merger

Pending

Friendly

Acquisition

Majority

Public

Biotechnology

vitro diagnostic tests

France

theranostics tests

Domestic

Single Bidder

Synopsis

Edit

Biosynex, a company that specializes in the design and distribution of rapid diagnostic tests, agreed to merge with Theradiag, a company that specializes in biotherapy monitoring. Financial terms were not disclosed.

Biosynex to merge with Theradiag.

target

bidder

legal advisors